Remdesivir

Muslims in India turn mosques, seminaries into Covid centres as cases surge

Muslims in several parts of India turn mosques and Islamic schools into Covid-19 care facilities to aid patients as the country's healthcare system is overwhelmed with rising cases.

Turkey set for first human trial of its virus vaccine – latest updates

More than 37 million people have tested positive for Covid-19 globally, while at least 1,070,000 have died from the virus. Here are the updates for October 9:

'Don't be afraid,' Trump says of virus spreading through US and White House

"Don't let it dominate you. Don't be afraid of it," US President has said in a video after his return from the Walter Reed Medical Center military hospital outside Washington, minimising the risk of Covid-19.

Trump leaves hospital briefly to greet supporters outside

US President Trump's medical team says his condition is improving continuously and that he is likely to be discharged from hospital as early as on Monday.

Doctors: Covid-hit Trump doing 'very well' in hospital

US President Trump is "doing very well" and is up and moving about as he undergoes treatment for Covid-19, according to his medical staff, but a top White House officials says next 48 hours critical.

EU buys remdesivir to treat 30,000 coronavirus patients

EU says it has agreed to pay $74 million to US drugmaker Gilead to address "just immediate needs," and is working to secure new doses from October.

WHO sees initial Covid-19 drug trial results within next two weeks

Mike Ryan, head of the WHO's emergencies programme, said it would be unwise to predict when a vaccine could be ready against Covid-19, the respiratory disease that has killed more than half a million people.

Global tourism faces up to $3.3-trillion hit from Covid-19 – latest updates

Novel coronavirus has infected more than 10.6 million people around the world, killing at least 515,000 people. Here are updates for July 1:

Germany says remdesivir supplies sufficient to treat Covid-19 patients

Germany says it is banking on developer Gilead Sciences to meet future needs and South Korea plans for an August purchase of the coronavirus treatment. Earlier the US said it had tied up nearly all of the drug's supply over the next three months.

Exorbitant price of Gilead's Covid-19 drug irks consumer groups

“We’re in uncharted territory with pricing a new medicine, a novel medicine, in a pandemic,” Gilead’s chief executive, Dan O’Day has said.

Anti-viral remdevisir gets EU endorsement as first Covid-19 drug

European Medicines Agency said that remdesivir is now the first medicine for Covid-19 to be recommended for authorisation in the EU.

Bangladesh's Beximco to begin producing Covid-19 drug remdesivir - official

Remdesivir, a drug developed by Gilead Sciences, has grabbed attention as one of the most promising treatments for Covid-19, the respiratory disease caused by the novel coronavirus, which has killed more than 250,000 people.